サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1526323

バイオチップの世界市場

Biochips

出版日
ページ情報
英文 369 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.02円
バイオチップの世界市場
出版日: 2024年08月05日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 369 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオチップの世界市場は2030年までに448億米ドルに到達

2023年に193億米ドルと推定されるバイオチップの世界市場は、2023年から2030年にかけてCAGR 12.8%で成長し、2030年には448億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるDNAチップは、CAGR 11.6%を記録し、分析期間終了までに147億米ドルに達すると予測されます。ラボオンチップ分野の成長率は、分析期間中CAGR13.4％と推定されます。

米国市場は70億米ドルと推定、中国はCAGR14.8%で成長予測

米国のバイオチップ市場は、2023年に70億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに42億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは14.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ10.7%と11.3%と予測されています。欧州では、ドイツがCAGR約12.5%で成長すると予測されています。

世界のバイオチップ市場- 主要動向と促進要因まとめ

バイオチップは、数百または数千の生化学反応を同時に実行できる小型ラボであり、医療診断、ゲノミクス、医薬品開発など様々な分野で大きな可能性を提供しています。一般的にシリコンやガラス基板から作製されるこれらの小さなデバイスは、マイクロアレイとマイクロ流体工学を統合し、生物学的物質を高精度で高速に分析します。バイオチップは、DNA、RNA、タンパク質、低分子を分析することができ、遺伝子配列決定、遺伝子発現プロファイリング、バイオマーカー検出に不可欠なツールとなっています。臨床診断において、バイオチップは特定の遺伝子マーカーや病原体を特定することにより、迅速かつ正確な病気の発見を可能にし、早期診断や個人に合わせた治療計画を容易にします。大規模なスクリーニングを効率的かつコスト効率よく実施する能力は、生物医学研究と臨床実践に革命をもたらしました。

技術の進歩は、バイオチップの能力と応用を著しく向上させました。微細加工技術の革新は、微量の生物学的物質も検出できる、より高度で高感度なバイオチップの開発につながりました。高度なセンサーやイメージングシステムとバイオチップの統合により、分析性能が向上し、リアルタイムモニタリングやハイスループット分析が可能になりました。さらに、すべての検査機能を1チップに小型化・集積化したラボオンチップ技術の登場により、バイオチップの応用範囲は、従来の研究室だけでなく、ポイントオブケア診断やフィールドアプリケーションにまで広がっています。この技術により、サンプルの迅速なオンサイト分析が可能となり、特に資源が限られた環境やリアルタイムでの疾病発生モニタリングに有益です。

バイオチップ市場の成長は、いくつかの要因によってもたらされます。慢性疾患や感染症の蔓延が進んでいるため、高度な診断ツールに対する需要が高まっており、臨床現場でのバイオチップの採用が進んでいます。バイオチップは、様々ながんを治療するための個別化された標的薬の開発にますます使用されるようになっています。健康的なライフスタイルの維持に対する消費者の関心の高まりも、チップの需要拡大をもたらしています。マイクロアレイやマイクロフルイディクス技術の進歩は、効率と精度を向上させ、ゲノミクスやプロテオミクス研究での利用を促進しています。バイオチップは個人の遺伝子プロファイルに基づいて治療を調整する機能を提供するため、個別化医療への注目の高まりと正確で迅速な診断ソリューションへのニーズも重要な促進要因となっています。さらに、ゲノム研究や高度な診断技術の開発を支援する政府の資金援助やイニシアチブも、市場の成長を後押ししています。環境モニタリング、食品安全検査、バイオテロ検知におけるバイオチップの用途拡大は、その使用に新たな道を開き、市場拡大をさらに促進しています。これらの要因が相まって、バイオチップ市場はダイナミックかつ急速に成長しており、バイオテクノロジー分野における技術革新と市場開拓の大きなチャンスとなっています。

調査対象企業の例（注目の合計69社）

  • Eppendorf AG
  • Fluidigm Corporation
  • F. Hoffmann-La Roche AG
  • IntegraGen SA
  • Agendia NV
  • Ocimum Biosolutions Ltd.
  • Analis SA/NV
  • Empire Genomics LLC
  • Mobidiag
  • AVIVA BioSciences Corporation
  • Little Things Factory GmbH
  • IDEX Health & Science LLC
  • Arround Inc.
  • As One Corporation
  • Cala Del Forte

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • ラテンアメリカ
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-1026

Global Biochips Market to Reach US$44.8 Billion by 2030

The global market for Biochips estimated at US$19.3 Billion in the year 2023, is expected to reach US$44.8 Billion by 2030, growing at a CAGR of 12.8% over the analysis period 2023-2030. DNA Chip, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$14.7 Billion by the end of the analysis period. Growth in the Lab-on-a-Chip segment is estimated at 13.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.0 Billion While China is Forecast to Grow at 14.8% CAGR

The Biochips market in the U.S. is estimated at US$7.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 14.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.7% and 11.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Global Biochips Market - Key Trends & Drivers Summarized

Biochips are miniature laboratories that can perform hundreds or thousands of simultaneous biochemical reactions, offering vast potential in various fields such as medical diagnostics, genomics, and drug development. These tiny devices, typically fabricated from silicon or glass substrates, integrate microarrays and microfluidics to analyze biological materials with high precision and speed. Biochips can analyze DNA, RNA, proteins, and small molecules, making them essential tools in genetic sequencing, gene expression profiling, and biomarker detection. In clinical diagnostics, biochips enable rapid and accurate detection of diseases by identifying specific genetic markers or pathogens, thus facilitating early diagnosis and personalized treatment plans. Their ability to conduct large-scale screenings efficiently and cost-effectively has revolutionized biomedical research and clinical practices.

Technological advancements have significantly enhanced the capabilities and applications of biochips. Innovations in microfabrication techniques have led to the development of more sophisticated and sensitive biochips, capable of detecting even minute quantities of biological substances. The integration of advanced sensors and imaging systems with biochips has improved their analytical performance, enabling real-time monitoring and high-throughput analysis. Additionally, the advent of lab-on-a-chip technology, which miniaturizes and integrates all laboratory functions on a single chip, has expanded the application scope of biochips beyond traditional research labs to point-of-care diagnostics and field applications. This technology allows for the rapid, on-site analysis of samples, which is particularly beneficial in resource-limited settings and for real-time disease outbreak monitoring.

The growth in the biochips market is driven by several factors. The increasing prevalence of chronic and infectious diseases has heightened the demand for advanced diagnostic tools, propelling the adoption of biochips in clinical settings. Biochips are being increasingly used in the development of personalized and targeted drugs for treating various cancers. Increasing interest among consumers in maintaining healthy lifestyles has also been resulting in demand growth for the chips.  Technological advancements in microarray and microfluidics technology are enhancing the efficiency and accuracy of biochips, encouraging their widespread use in genomics and proteomics research. The rising focus on personalized medicine and the need for precise and rapid diagnostic solutions are also significant drivers, as biochips offer the capability to tailor treatments based on individual genetic profiles. Furthermore, government funding and initiatives supporting genomics research and the development of advanced diagnostic technologies are boosting market growth. The expanding applications of biochips in environmental monitoring, food safety testing, and bioterrorism detection are opening new avenues for their use, further driving market expansion. Together, these factors are fostering a dynamic and rapidly growing market for biochips, presenting significant opportunities for innovation and development in the field of biotechnology.

Select Competitors (Total 69 Featured) -

  • Eppendorf AG
  • Fluidigm Corporation
  • F. Hoffmann-La Roche AG
  • IntegraGen SA
  • Agendia NV
  • Ocimum Biosolutions Ltd.
  • Analis SA/NV
  • Empire Genomics LLC
  • Mobidiag
  • AVIVA BioSciences Corporation
  • Little Things Factory GmbH
  • IDEX Health & Science LLC
  • Arround Inc.
  • As One Corporation
  • Cala Del Forte

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Biochips - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Biochips: A Primer
    • Manufacturing Systems Used in Biochip Manufacture
    • Historical Perspective
    • Classification of Biochips
    • Application Markets
    • Market Outlook
    • Protein Biochips Set for Expansion
    • Recent Technological Advancements Drive Wider Adoption of Biochips
    • Competition
    • Biotech Startups Pose Competition
    • Recent Market Activity
    • World Brands
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Biochips Seek Increasing Role in POC Testing
    • Biochips to Help Next-Generation Sequencing Scale New Heights & Unravel Intimidating Biological Problems
    • Research Forays into Organ-On-A-Chip (OOC)
    • OCC Start-Ups Enter the Fray
    • Select Organ-On-A-Chip Start-Ups & Their Specialties
    • Biochip Implants Set to Make Big Gains
    • Biochips Aid in Alleviating Issues Associated with Immunological Studies
    • Challenges for Widespread Adoption
    • Drug Discovery Applications to Drive Market
    • Growing Preference for DNA/Protein Biochips in Personalized Medicine
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • Microphysiological Systems to Take Personalized Medicine Much Farther
    • Biochip Array Technology Enables Reliable and Accurate Investigation of Metabolic Syndrome
    • Proteomics and Genomics Drive Opportunities for Biochips
    • Increasing Application of Genomics and Proteomics in Cancer Diagnostics and Treatment to Drive Growth
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Potential Application of Biochips in Diabetes Diagnosis and Management Unfurl New Growth Opportunities
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Rise in Infectious Diseases and Need for High-Troughput Diagnosis Drive Interest in Biochips
    • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
    • Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
    • Agriculture Sector: Niche Vertical
    • Development of Protein Microarrays for the Field of Diagnostics: Key Challenges
    • Biochip Industry Thrives on Innovation
    • Researchers at UCI Develop Machine Learning-Assisted Biochip
    • New Biochip Combines Nanoparticle Printing and AI for Tumor Analysis
    • Axbio Introduces Smartbiochip
    • Multi-Dimensional Printing Technology Enables Development of New Biochip Printing Technique
    • MIT Develops Neuromorphic Chip Capable of Mimicking Human Brain
    • Biochips from AYOXXA: A Giant Leap in Protein Multiplexing
    • Biochip Innovations in Drug Discovery Applications
    • Industry Challenges
    • Standardization: A Key Challenge
    • High Costs Restrain Growth
    • Precise Protein Detection: A Challenge
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for DNA Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for DNA Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for DNA Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Protein Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Protein Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Protein Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Agriculture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Biochips Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 116: Latin America Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Latin America Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Latin America 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 119: Latin America Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Latin America Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Latin America 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of World Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of World 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of World Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of World Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of World 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION